HEPION PHARMACEUTICALS, INC. Payments of Stock Issuance Costs
HEPION PHARMACEUTICALS, INC. (HEPA) reported Payments of Stock Issuance Costs of $30.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. payments of stock issuance costs for the quarter ending 2025-03-31 was $802.60K.
- HEPION PHARMACEUTICALS, INC. payments of stock issuance costs for fiscal 2025 was $802.60K.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 11 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-13 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $802.60K 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $802.60K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $802.60K 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | $802.60K 10-Q · filed 2026-05-14 | |||||
| 2025-01-23 | $800.00K 10-Q · filed 2026-08-13 | |||||
| 2024-02-16 | $209.12K 10-Q · filed 2024-05-21 | |||||
| 2019-06-18 | $1.40M 10-K · filed 2020-05-14 | |||||
| 2019-04-25 | $400.00K 10-K · filed 2020-05-14 | |||||
| 2018-07-03 | $900.00K 10-K · filed 2020-05-14 | |||||
| 2014-03-31 | $15.03K 10-Q · filed 2014-05-15 | $15.03K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |